|
Final Agenda Stakeholder Event on Biosimilar Medicinal Products - 14/09/2018
Datum dokumenta: Thu Sep 13 00:00:00 CEST 2018
- Ustvaril GROW.DDG1.D.DIR
- Datum objave: Mon Sep 17 15:19:50 CEST 2018
- Zadnja sprememba: Mon Sep 17 15:20:02 CEST 2018
|
|
Improving understanding of biosimilars across the EU
Datum dokumenta: Thu Sep 13 00:00:00 CEST 2018
- Ustvaril GROW.DDG1.D.DIR
- Datum objave: Fri Sep 28 16:16:22 CEST 2018
- Zadnja sprememba: Fri Sep 28 16:16:34 CEST 2018
|
|
Biosimilars in the EU - Information guide for healthcare professionals
Datum dokumenta: Wed Apr 26 00:00:00 CEST 2017
- Ustvaril GROW.DDG1.D.1
- Datum objave: Wed May 03 10:10:13 CEST 2017
- Zadnja sprememba: Wed May 03 10:10:33 CEST 2017
|
|
EC Stakeholder Workshop on Biosimilars 5 May 2017 final draft agenda
Datum dokumenta: Mon Apr 24 00:00:00 CEST 2017
- Ustvaril GROW.DDG1.D.1
- Datum objave: Thu May 04 14:00:43 CEST 2017
- Zadnja sprememba: Thu May 04 14:01:00 CEST 2017
|
|
CHMP scientific opinion on the principal mode of action of proanthocyanidins intended to be used for prevention and treatment of urinary tract infections - Art. 57(1) of Regulation (EC) No 726/2004
Datum dokumenta: Thu Jul 21 00:00:00 CEST 2016
- Ustvaril GROW.DDG1.D.4
- Datum objave: Tue Nov 15 10:26:10 CET 2016
- Zadnja sprememba: Tue Nov 15 10:27:01 CET 2016
|
